News

RCMI Launched First Research Seminar Series with Science Luminaries

RCMI Participated in PolyU Innotech Open Day 2022

With a view to showcasing PolyU’s endeavours in interdisciplinary research, innovation, knowledge transfer and entrepreneurship to local, national and global audiences, PolyU organised the InnoTech Open Day on 16 July 2022 which offers a wide range of thrilling activities targeting innovation and technology (I&T) entrepreneurs, industry partners, researchers, young talents and students.   RCMI participated in the major highlights of the event: in the morning session, Dr Daniel Mok, Acting DoRCMI, graced the PAIR inauguration ceremony with RI/RC Directors under PAIR to mark the official launch of the largest interdisciplinary research in Hong Kong and the GBA;  In the afternoon session, in addition to exhibition booth showcasing the Centre’s research directions and funded projects, the Centre also joined hands with Research Institute for Future Food (RiFood) to host a parallel session themed “Health Food & Lifestyle Management” to enhance public’s understanding of promoting optimal health with TCM. RCMI is delighted to have Dr Jessie Lin, Research Assistant Professor of Rehabilitation Science as the speaker.”, Dr Lin’s sharing, entitled “TCM Based Lifestyle Management for Improving Personal Health and Wellness, featured major TCM-based lifestyle management techniques, their therapeutic and antidepressant effects as well as related RCMI funded projects. The sharing was followed by a Panel Discussion led by Dr Daniel Mok, Acting DoRCMI and Dr Wong Ka Hing, DoRiFood with fruitful exchange.   To sustain our momentum in elucidating the scientific value of TCM, The highlights of July, RCMI’s Research Seminar Series: Forum on Development and Innovation of Traditional Chinese Medicine, will be held on 29 July (Friday) from 10am to 12pm via Zoom. For registration, please visit: https://polyu.zoom.us/meeting/register/tJIlc-GvpzkqHtwIqw2eix6qKm9ED4jU6eqS For more details, please visit: https://www.polyu.edu.hk/rcmi/news-and-events/event/2022/july-2022/rcmi-research-seminar-series--forum-on-development-and-innovation-of-traditional-chinese-medicine/?sc_lang=en  

RCMI Members featured on TVB program

Normal 0 false false false EN-HK ZH-CN X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} Prof. Wong Man-sau, Director of Research Centre for Chinese Medicine Innovation, Dr Daisy Zhao,  Assistant Professor, RiFood and RCMI Member, and Dr Christina Poon, Research Assistant Professor of RCMI, were featured on TVB program “100 Health Tips” debunking health myths, such as the effectiveness of soy milk in prevention of osteoporosis and premenopausal breast cancer as well as how cooking methods impact the nutritional value of the food.

PolyU collaborates with Increasepharm (HK) Limited for CM-based new drug development

PolyU received generous support of HK $10 million from Increasepharm (HK) Limited to establish the PolyU – Increasepharm Joint Research Laboratory for New Drug Development (“The Joint Laboratory”). A signing ceremony was held on 15 June 2022 via hybrid mode. During the ceremony, Prof. Zhang Baoxian, Chairman of Beijing Increasepharm Corporation Limited stated that The Joint Laboratory would capitalise on the opportunities brought by the country’s development, further extend the strategic partnership towards the Greater Bay Area (GBA) and conduct cutting-edge collaborative researches on developing nanomedicine and aerosolized medications for treating ocular diseases and osteoporosis. The Joint Laboratory is under the PolyU Research Centre for Chinese Medicine Innovation (RCMI). Prof. Wong Man-sau, Director of RCMI, expressed her gratitude to Prof. Zhang and said, “The establishment of The Joint Laboratory would strengthen the current collaborative researches on osteoporosis drug development. On one hand, it would leverage the advantages of Increasepharm in synthetic chemistry and industrialisation of new drugs, making the pathway for the industrialisation of PolyU’s pharmaceutical research results. The Joint Laboratory would be committed to developing a series of herbal-based small-molecule drug, including innovative drugs for treatment of dementia and prevention of cognitive decline; On the other hand, it would explore and deliver innovative drugs for the treatment of ophthalmic diseases with the Novel Drug Delivery System. The Joint Laboratory would not only complement each other’s research strengths and technological capabilities but also provide a training base to all parties concerned.”

PolyU scholar on relieving long COVID symptoms with TCM

Dr Jerry Yeung, Management Committee member of RCMI, also Associate Professor of PolyU’s School of Nursing, introduced how to relieve long COVID symptoms with traditional Chinese medicine (TCM) approach, including acupoint stimulation and acupuncture, on RTHK TV programme “Healthpedia”.   RTHK - https://polyu.me/3NfV9Xs  (14:40 - 34:35)